Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for pemetrexed
Perform Another (Advanced) Search
Related Words: pemetrexed
220 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
Displaying results 1—20
Next > Last »
1. Study Posting (2917) Trial #158857, Non-Small Cell Lung Cancer, Beech Grove, IN ...II Trial of Docetaxel, Carboplatin and Bevacizumab as First-Line Treatment, Followed by Bevacizumab plus Pemetrexed versus Pemetrexed Alone as Second-Line Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer ...View Page
2. Clinical Trial Results by Drug Names ...Result Information Title of Study: A phase 1B study of erlotinib (Tarceva) in combination with pemetrexed (Alimta) in NSCLC. Fast Facts: Protocol number: BP18193 Sponsor: Hoffmann-La Roche Ltd Company division ......maximum tolerated dose (MTD) and safety profile of a combination of Tarceva (erlotinib) and Alimta (pemetrexed) in patients with non-small cell lung cancer (NSCLC). Study center(s) : 4 centers in ...View Page
3. Newly Approved Drug Therapies (849) Alimta (pemetrexed for injection), Eli Lilly, ...Newly Approved Drug Therapies (849) Alimta (pemetrexed for injection), Eli Lilly, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Alimta (pemetrexed for injection) Company: Eli Lilly Approval Status: Approved February 2004 Treatment Area: Mesothelioma General Information ...View Page
4. Study Posting (2246) Trial #155617, Lung Cancer, Duarte, CA ...Study Posting (2246) Trial #155617, Lung Cancer, Duarte, CA Trial Information Phase 3 Study of Pemetrexed, Cisplatin and Radiotherapy followed by Consolidation Pemetrexed v Etoposide, Cisplatin and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with ...View Page
5. Study Posting (4519) Trial #157934, Non-Small Cell Lung Cancer, Izmir, Turkey ...Cancer, Izmir, Turkey Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
6. Study Posting (4519) Trial #157928, Non-Small Cell Lung Cancer, Antalya, Turkey ...Cancer, Antalya, Turkey Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
7. Study Posting (4519) Trial #158016, Non-Small Cell Lung Cancer, Ankara, Turkey ...Cancer, Ankara, Turkey Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
8. Study Posting (4519) Trial #158105, Non-Small Cell Lung Cancer, Zürich, Switzerland ...Cancer, Zürich, Switzerland Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
9. Study Posting (4519) Trial #158011, Non-Small Cell Lung Cancer, Uppsala, Sweden ...Cancer, Uppsala, Sweden Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
10. Study Posting (4519) Trial #158012, Non-Small Cell Lung Cancer, Lund, Sweden ...Cancer, Lund, Sweden Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
11. Study Posting (4519) Trial #157973, Non-Small Cell Lung Cancer, Linkoeping, Sweden ...Cancer, Linkoeping, Sweden Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
12. Study Posting (4519) Trial #158000, Non-Small Cell Lung Cancer, Palma de Mallorca, Spain ...de Mallorca, Spain Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
13. Study Posting (4519) Trial #157866, Non-Small Cell Lung Cancer, Madrid, Spain ...Cancer, Madrid, Spain Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
14. Study Posting (4519) Trial #157927, Non-Small Cell Lung Cancer, La Laguna, Spain ...La Laguna, Spain Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
15. Study Posting (4519) Trial #158132, Non-Small Cell Lung Cancer, St Petersburg, Russian Federation ...Petersburg, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
16. Study Posting (4519) Trial #157903, Non-Small Cell Lung Cancer, Moscow, Russian Federation ...Moscow, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
17. Study Posting (4519) Trial #158049, Non-Small Cell Lung Cancer, Krasnodar, Russian Federation ...Krasnodar, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
18. Study Posting (4519) Trial #158046, Non-Small Cell Lung Cancer, Irkutsk, Russian Federation ...Irkutsk, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
19. Study Posting (4519) Trial #158042, Non-Small Cell Lung Cancer, Balashikha, Russian Federation ...Balashikha, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
20. Study Posting (4519) Trial #157971, Non-Small Cell Lung Cancer, Porto, Portugal ...Cancer, Porto, Portugal Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ......Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.